Together, these results demonstrate that PI3K/Akt signaling inactivates proapoptotic signaling in CRPC cells and targeting this alternative pathway is a potential strategy to increase apoptotic response in both PTEN‐mutant and PTEN–wild‐type prostate tumors. This evidence concerns the gene PTEN and prostate neoplasm.